ScholarIQanswers from OpenAlex
International Journal of Hematology
JournalCitation impact & published research
International Journal of Hematology is a journal indexed in ScholarIQ from OpenAlex.
How many works does International Journal of Hematology have?
ScholarIQindexed works
International Journal of Hematology has 6,100 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does International Journal of Hematology have?
ScholarIQcitation count
International Journal of Hematology has 97,421 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of International Journal of Hematology?
ScholarIQh-index
International Journal of Hematology has an h-index of 100 in OpenAlex.
What is the article processing charge of International Journal of Hematology?
ScholarIQarticle processing charge
International Journal of Hematology lists an article processing charge of 3,990 USD in OpenAlex.
What is the OpenAlex record for International Journal of Hematology?
ScholarIQopenalex
The OpenAlex for International Journal of Hematology is on the source record.
What are the most-cited papers on International Journal of Hematology?
ScholarIQmost cited works
Prevalence and Clinical Characteristics of Acute Myeloid Leukemia Associated with Disseminated Intravascular Coagulation
Hideki Uchiumi, Takafumi Matsushima, Arito Yamane, Noriko Doki, Hiroyuki Irisawa, Takayuki Saitoh, Tohru Sakura, Takahiro Jimbo, Hiroshi Handa, Norifumi Tsukamoto, Masamitsu Karasawa, Shuichi Miyawaki, Hirokazu Murakami, Yoshihisa Nojima
Chinese guidelines for treatment of adult primary immune thrombocytopenia
Xinguang Liu, Bai Xiao-chuan, Fangping Chen, Yunfeng Cheng, Kesheng Dai, Meiyun Fang, Jianming Feng, Yuping Gong, Tao Guo, Xinhong Guo, Yue Han, Luojia Hong, Yu Hu, Baolai Hua, Ruibing Huang, Yan Li, Jun Peng, Mi-Mi Shu, Jing Sun, Peiyan Sun, Yuqian Sun, Chun-sen Wang, Shujie Wang, Xiaomin Wang, Congming Wu, Wenman Wu, Zhenyu Yan, Feng'e Yang, Linhua Yang, Renchi Yang, Tonghua Yang, Ye Xu, Guangsen Zhang, Lei Zhang, Changcheng Zheng, Hu Zhou, Min Zhou, Rongfu Zhou, Zeping Zhou, Hongli Zhu, Tienan Zhu, Ming Hou
Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial
Yuzuru Kanakura, Kazuma Ohyashiki, Tsutomu Shichishima, Shinichiro Okamoto, Kiyoshi Ando, Haruhiko Ninomiya, Tatsuya Kawaguchi, Shinji Nakao, Hideki Nakakuma, J Nishimura, Taroh Kinoshita, Camille L. Bedrosian, Marye Ellen Valentine, Gus Khursigara, Keiya Ozawa, Mitsuhiro Omine
Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trial
Yuzuru Kanakura, Kazuma Ohyashiki, Tsutomu Shichishima, Shinichiro Okamoto, Kiyoshi Ando, Haruhiko Ninomiya, Tatsuya Kawaguchi, Shinji Nakao, Hideki Nakakuma, J Nishimura, Taroh Kinoshita, Camille L. Bedrosian, Keiya Ozawa, Mitsuhiro Omine
Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan
Haruhiko Ninomiya, Naoshi Obara, Shigeru Chiba, Kensuke Usuki, Kaichi Nishiwaki, Itaru Matsumura, Tsutomu Shichishima, Shinichiro Okamoto, J Nishimura, Kazuma Ohyashiki, Shinji Nakao, Kiyoshi Ando, Yoshinobu Kanda, Tatsuya Kawaguchi, Hideki Nakakuma, Daisuke Harada, H Akiyama, Taroh Kinoshita, Keiya Ozawa, Mitsuhiro Omine, Yuzuru Kanakura